Randomised controlled trial comparing voltarol and paracetamol analgesia following oocyte collection in in vitro fertilisation (IVF) patients.

2012 ◽  
Author(s):  
Gavin Sacks
BMJ ◽  
2010 ◽  
Vol 341 (sep30 2) ◽  
pp. c2501-c2501 ◽  
Author(s):  
A. van Peperstraten ◽  
W. Nelen ◽  
R. Grol ◽  
G. Zielhuis ◽  
E. Adang ◽  
...  

2020 ◽  
Author(s):  
Priya Bhide ◽  
Arasaratnam Srikanthara ◽  
Doris Lanz ◽  
Julie Dodds ◽  
Bonnie Collins ◽  
...  

Abstract • Background: Subfertility is a common problem for which in-vitro fertilisation (IVF) treatment is commonly recommended. Success rates following IVF are suboptimal and have remained static over the last few years. This imposes a considerable financial burden on overstretched healthcare resources. Time-lapse imaging (TLI) of developing embryos in IVF treatment is hypothesised to improve the success rates of treatment. This may be either by providing undisturbed culture conditions and/or improving the predictive accuracy for optimal embryo selection from a cohort of available embryos. However, current best evidence for its effectiveness is inconclusive. • Methods: The time-lapse imaging trial is a pragmatic, multi-centre, three-arm parallel group randomised controlled trial using re-randomisation. The primary objective of the trial is to determine if the use of TLI or undisturbed culture in IVF treatment results in a higher live birth rate when compared to current standard methods of embryo incubation and assessment. Secondary outcomes include measures of clinical efficacy and safety. The trial will randomise 1575 participants to detect an increase in live birth from 26.5% to 35.25%.• Discussion: In the absence of high quality evidence, there is no current national guidance, recommendation or policy for the use of TLI. The use of TLI is not consistently incorporated into standard IVF care. A large, pragmatic, multicentre, trial will provide much needed definitive evidence regarding the effectiveness of TLI. If proven to be effective, its incorporation into standard care would translate into significant clinical and economic benefits. If not, it would allow allocation of resources to more effective interventions.• Trial registration: ISRCTN registry, ISRCTN17792989, 18/04/2018, prospectively registered.


The Lancet ◽  
2016 ◽  
Vol 387 (10038) ◽  
pp. 2622-2629 ◽  
Author(s):  
Janine G Smit ◽  
Jenneke C Kasius ◽  
Marinus J C Eijkemans ◽  
Carolien A M Koks ◽  
Ronald van Golde ◽  
...  

The Lancet ◽  
2016 ◽  
Vol 387 (10038) ◽  
pp. 2614-2621 ◽  
Author(s):  
Tarek El-Toukhy ◽  
Rudi Campo ◽  
Yacoub Khalaf ◽  
Carla Tabanelli ◽  
Luca Gianaroli ◽  
...  

BMJ Open ◽  
2018 ◽  
Vol 8 (12) ◽  
pp. e023413 ◽  
Author(s):  
Lan N Vuong ◽  
Vu N A Ho ◽  
Tuong M Ho ◽  
Vinh Q Dang ◽  
Tuan H Phung ◽  
...  

IntroductionIn vitro maturation (IVM) is a potential alternative to conventional in vitro fertilisation (IVF) to avoid ovarian hyperstimulation syndrome (OHSS). This is particularly relevant in women with a high antral follicle count (AFC) and/or polycystic ovary syndrome (PCOS), who are at increased risk for OHSS. However, no randomised controlled trials of IVM versus IVF in women with high AFC have reported both pregnancy and OHSS rates. The aim of this study is to compare the effectiveness and safety of one IVM cycle and one IVF with segmentation cycle within women with PCOS or high AFC-related subfertility.Methods and analysisThis randomised controlled trial will be conducted at a specialist IVF centre in Vietnam. Eligible subfertile women with PCOS and/or high AFC will be randomised to undergo either IVM or IVF. The primary outcome is live birth after the first embryo transfer of the started treatment cycle. Cycles in which no embryo is available for transfer will be considered as failures. The study has a non-inferiority design, with a maximal acceptable between-group difference of 5%. Rates of OHSS will also be reported.Ethics and disseminationEthical approval was obtained from the participating centre, and informed patient consent was obtained before study enrolment. Results of the study will be submitted for publication in a peer-reviewed journal.Trial registration numberNCT03405701; Pre-results.


Sign in / Sign up

Export Citation Format

Share Document